Abbott’s Freestyle Libre 3 Combine with Automated Insulin Delivery System Mylife Loop in Germany
Shots:
- The company highlighted the compatibility b/w FreeStyle Libre 3 sensor & mylife Loop from Ypsomed & CamDiab. The combined technologies develop a smart, automated process for insulin delivery based on real-time glucose data
- The companies launched their automated insulin delivery (AID) system in Germany & intend to offer it in additional EU countries in 2023 that was designed for the Ypsomed mylife YpsoPump to combine with the CamDiab's CamAPS FX mobile app & FreeStyle Libre 3
- It monitors the user’s glucose levels, automatically adjusts & delivers the right amount of insulin to eliminate the guesswork of insulin dosing & helps diabetes patients to reach better treatment targets. The company plans to make FreeStyle Libre interoperable with other leading insulin delivery systems
Ref: Abbott | Image: Abbott
Realted Posts:- Abbott Presents Results of Freestyle Libre 3 System for the Treatment of Type 1 or Type 2 Diabetes at ADA 2022
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
